Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Millennials can benefit from strategic wealth management. Discover tips to effectively grow and manage your financial assets.
18,493 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Apple and Nvidia sit at the pinnacle of market caps, but they play very different roles in investors’ portfolios. Thi...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
HF Sinclair delivered a solid earnings beat, but shares fell sharply after leadership news. This article breaks down ...
Saluda Grade taps Patrick Lo to join co-CIO leadership and broaden its asset-based finance platform. The move positio...
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Two major travel stocks have caught the eye of billionaire activist investors. This article breaks down what could ha...
When figma stock popped today, investors watched for catalysts beyond a single headline. This guide breaks down the d...
Magnite's 2025 earnings outlook centers on growing connected TV demand, platform efficiency, and navigating ad-tech p...
The latest Shake Shack earnings sparked a notable stock rally. This article breaks down the factors driving the move,...
Paramount’s move to revive G.I. Joe with a controversial hire is more than a movie decision—it’s a case study in risk...
AST SpaceMobile faces a pivotal Q4 2025 print after the bell on March 2, 2026, with analysts eyeing a revenue uptick ...